Tadeusz Robak
Pabianicka 62 St
Lodz, LD 93513, Poland
Lodz, LD 93513, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 347 publications
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.
Journal: Leukemia & lymphoma
Published: August 10, 2026
BTK Inhibitors for the Treatment of Mantle Cell Lymphoma-Current Status and Perspectives.
Journal: Cancers
Published: July 08, 2026
The preclinical discovery and development of acalabrutinib for the treatment of mantle cell lymphoma.
Journal: Expert opinion on drug discovery
Published: June 15, 2026
Autoimmune cytopenias in chronic lymphocytic leukemia in the era of novel drugs.
Journal: Expert review of hematology
Published: June 02, 2026
From covalent to reversible: the expanding role of BTK inhibitors in chronic lymphocytic leukemia.
Journal: Expert opinion on pharmacotherapy
Published: May 29, 2026
Advancing Immunotherapy in Chronic Lymphocytic Leukemia.
Journal: International journal of molecular sciences
Published: March 02, 2026
Predicted microbiome-associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia.
Journal: British journal of haematology
Published: February 25, 2026
EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation.
Journal: HemaSphere
Published: February 06, 2026
Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.
Journal: Blood
Published: January 05, 2026
Efficacy and Safety of Avatrombopag Treatment in Immune Thrombocytopenia Patients in Poland: A Multicenter Study.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: December 27, 2025
Cutaneous Adverse Effects in Patients Treated with BTK Inhibitors.
Journal: Cancers
Published: December 20, 2025
Last Updated: 09/26/2026